Background: A meta-analysis was conducted to summarize the evidence from prospective cohort and case-control studies regarding the association between coffee intake and biliary tract cancer (BTC) and liver cancer risk. Methods: Eligible studies were identified by searches of PubMed and EMBASE databases from the earliest available online indexing year to March 2017. The dose-response relationship was assessed by a restricted cubic spline model and multivariate random-effect meta-regression. A stratified and subgroup analysis by smoking status and hepatitis was performed to identify potential confounding factors. Results: We identified five studies on BTC risk and 13 on liver cancer risk eligible for meta-analysis. A linear dose-response meta-analysis did not show a significant association between coffee consumption and BTC risk. However, there was evidence of inverse correlation between coffee consumption and liver cancer risk. The association was consistent throughout the various potential confounding factors explored including smoking status, hepatitis, etc. Increasing coffee consumption by one cup per day was associated with a 15% reduction in liver cancer risk (RR 0.85; 95% CI 0.82 to 0.88). Conclusions: The findings suggest that increased coffee consumption is associated with decreased risk of liver cancer, but not BTC.
Introduction
Coffee is one of the most consumed beverages worldwide and it has been associated with a number of benefits on human health including a decreased risk of all-cause, cardiovascular, and cancer mortality [1] [2] [3] . Coffee is composed of a variety of compounds, some of which have been reported to have an impact on liver health [4] . Caffeine, a major component in coffee has been proposed to exert anti-carcinogenic effects toward up-regulation of antioxidant-responsive element (ARE)-mediated signalling [5] , while phenolic compounds in coffee have been shown to exert anti-oxidant and anti-inflammatory effects [6] . In addition, coffee diterpenes have potential anti-carcinogenic effects [6] .
Materials and Methods
Meta-Analysis of Observational Studies in Epidemiology (MOOSE) protocols were followed throughout design, execution, analysis and reporting of this meta-analysis (Table S1 ) [16] .
Search Strategy
We conducted a comprehensive literature search using PubMed (http://www.ncbi.nlm.nih.gov/ pubmed/) and EMBASE (http://www.embase.com/) databases from the earliest available online indexing year to March 2017, with English-language restriction. Search terms included the following: (coffee OR caffeine OR beverages) and (extrahepatic OR gallbladder OR biliary tract OR liver OR hepatocellular) and (cancer OR carcinoma OR neoplasm) (Table S2) . Two authors separately screened and retrieved the studies. We included prospective and case-control studies that evaluated association between dietary coffee intake and risk of extrahepatic/hepatic cancer in generally healthy adults. Studies were included if they provided corresponding risk estimates such as RRs (Risk Ratios), HRs (Hazard Ratios), or ORs (Odds Ratios). We excluded studies that reported insufficient statistics or insufficient coffee consumption categories (less than three; Table S3 ). Reference lists of included manuscripts were also examined for additional studies not previously identified. When duplicate publications from the same study were identified, we included the report that provided the largest number of cases/entire cohort or with the longest follow-up for each endpoint of interest. Full-texts of potentially relevant articles were assessed independently for eligibility by two authors.
Data Extraction
Data were abstracted from each identified study using a standardized extraction form. The following information was collected: (1) first author name; (2) year of publication; (3) study cohort name; (4) country; (5) number of participants; (6) sex of participants; (7) age range of the study population at baseline; (8) categories of consumption; (9) follow-up period; (10) 
endpoints and cases;
Nutrients 2017, 9, 950 3 of 17 (11) distributions of cases and person-years, HRs, and 95% CIs for all categories of exposure; and (12) covariates used in adjustments. This process was performed independently by two authors and discrepancies were discussed and resolved by consensus. The quality of included studies was assessed according to the Newcastle-Ottawa Quality Assessment Scale [17] , which consists of three variables of quality as follows, selection (4 points), comparability (2 points), and outcome (3 points), for a total score of 9 points (9 representing the highest quality).
Statistical Analysis
In this meta-analysis, ORs and HRs were deemed equivalent to relative risks (RRs) [18] . ORs, RRs and HRs with 95% CI for all categories of exposure were extracted for the analysis and random-effects models were used to calculate pooled RR with 95% CI for the highest versus lowest category of exposure. The highest versus lowest analysis was performed to determine the relationship between coffee intake and risk of BTC and liver cancer. We included gallbladder cancer and extrahepatic/intrahepatic bile duct cancer in the same analysis, as their aetiology is similar [7] . The risk estimate from the most fully adjusted models in the analysis of the pooled RR was used. Heterogeneity was assessed using the Q test and I 2 statistic. The level of significance equal to 0.10 was used for the Q test. The I 2 statistic represented the amount of total variation that could be attributed to heterogeneity. I 2 values ≤25%, 25-50%, 50-75%, and >75% indicated no, small, moderate, and significant heterogeneity, respectively. A sensitivity analysis by exclusion of one study at a time was performed to evaluate the stability of results and potential sources of heterogeneity. Subgroup analysis was only performed for liver cancer risk, in order to check for potential source of heterogeneity according to study design, gender and geographical area. To test for potential confounders/effect modifiers, subgroup analyses were performed according to smoking status, coffee type and hepatitis. Publication bias was evaluated by a visual investigation of funnel plots for potential asymmetry.
A dose-response analysis was performed using the method of Greenland and Longnecker to calculate study-specific liner and non-linear trend (generalized least-squares, GLS) based on results across categories of coffee intake [19, 20] . Data were extracted on the level of coffee intake, distributions of cases and person-years (when available), and ORs/RRs/HRs with 95% CIs for ≥3 exposure categories. The median or mean intake of coffee in each category was assigned to the corresponding OR/RR/HR with the 95% CI for each study. When coffee consumption was reported in a range of intake, the midpoint of the range was used. When the highest category was open ended, we assumed the width of the category to be the same as the adjacent category. When the lowest category was open ended, we set the lower boundary to zero. Two-stage random-effects dose-response meta-analysis was performed to examine linear and non-linear relationship between coffee intake and risk of biliary tract cancer and liver cancer. In the first stage the method of Greenland and Longnecker (generalized least-squares, GLS) was used to calculate study-specific coefficients on the basis of results across categories of coffee intake taking into account the correlation within each set of retrieved ORs/RRs/HRs [19, 20] . Non-linear dose-response analysis was modelled using restricted cubic splines with 3 knots at fixed percentiles (25%, 50%, and 75%) of the distribution [21] . The coefficients that had been estimated within each study by performing random-effects meta-analysis were combined. In linear dose-response meta-analysis the method of DerSimonian and Laird was used and in non-linear dose-response meta-analysis the multivariate extension of the method of moments was used to estimate the relative risks. We calculated an overall P-value by testing that the 2 regression coefficients were simultaneously equal to zero. We then calculated a P-value for non-linearity by testing that the coefficient of the second spline was equal to zero. All analyses were performed with R software Version 3.0.3, using dosresmeta and mvmeta packages (Development Core Team, Vienna, Austria). 
Results

Study Characteristics
The study selection process of eligible studies is presented in Figure 1 . For the analysis on the association between coffee consumption and BTC risk five studies were eligible [22] [23] [24] [25] [26] , one of which was a pooling project of nine cohort studies [25] , two were studies comprising three prospective cohorts [23, 24] , and two were case-control studies [22, 26] . Eligible studies included 1,375,626 participants and 726 BTC cases. The main characteristics of the studies included in the meta-analysis are summarized in Table 1 . Six studies provided data for men and women separately [25, [27] [28] [29] [30] [31] . Four studies provided data on type of coffee consumed [25, [32] [33] [34] , six on smoking status [25, 27, 28, 30, 31, 35] , and six on hepatitis [27, 29, 30, 33, 36, 37] . Three studies were conducted in USA [22, 25, 26] , one in Europe [23] and one in Asia [24] . The follow-up in prospective cohort studies ranged from about 13 to 20 years, and the age range at study baseline was 30-84 years.
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Study Characteristics
The study selection process of eligible studies is presented in Figure 1 . For the analysis on the association between coffee consumption and BTC risk five studies were eligible [22] [23] [24] [25] [26] , one of which was a pooling project of nine cohort studies [25] , two were studies comprising three prospective cohorts [23, 24] , and two were case-control studies [22, 26] . Eligible studies included 1,375,626 participants and 726 BTC cases. The main characteristics of the studies included in the meta-analysis are summarized in Table 1 . Six studies provided data for men and women separately [25, [27] [28] [29] [30] [31] . Four studies provided data on type of coffee consumed [25, [32] [33] [34] , six on smoking status [25, 27, 28, 30, 31, 35] , and six on hepatitis [27, 29, 30, 33, 36, 37] . Three studies were conducted in USA [22, 25, 26] , one in Europe [23] and one in Asia [24] . The follow-up in prospective cohort studies ranged from about 13 to 20 years, and the age range at study baseline was 30-84 years. Thirteen studies [25, [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] , including seven studies on six prospective cohorts and one multicentre study (EPIC) [28] [29] [30] [31] [32] 34, 38] , one pooling project of nine prospective cohorts [25] , and five case-control studies [27, 33, [35] [36] [37] , were eligible for the analysis on the association between coffee consumption and liver cancer. Eligible studies included 2,105,104 individuals and 4227 liver cancer cases. The main characteristics of the studies included in the meta-analysis are summarized in Table 1 . Two studies were conducted in USA [25, 34] , six in Europe [27, 28, [31] [32] [33] 36] , and five in Asia [29, 30, 35, 37, 38] . The follow-up in prospective cohort studies ranged from about 9 to 19 years, and the age range at study baseline was 20-79 years.
Summary Relative Risk for the Highest versus Lowest Category of Coffee Consumption
The summary RR of BTC for the highest versus lowest category of coffee consumption was 0.83, 95% CI: 0.64, 1.08, with no evidence of heterogeneity I 2 = 0%, p = 0.58 (Figure 2) . No publication bias was found after visual inspection of funnel plot ( Figure S1 ). The pooled estimations were RR = 0.84, 95% CI: 0.61, 1.15; I 2 = 22%, p = 0.27 for prospective cohort studies, and RR = 0.74, 95% CI: 0.34, 1.63; I 2 = 0%, p = 0.82 for case-control studies (Figure 2 ). The subgroup analysis was not performed due to the limited number of studies eligible for the meta-analysis.
Thirteen studies [25, [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] , including seven studies on six prospective cohorts and one multicentre study (EPIC) [28] [29] [30] [31] [32] 34, 38] , one pooling project of nine prospective cohorts [25] , and five case-control studies [27, 33, [35] [36] [37] , were eligible for the analysis on the association between coffee consumption and liver cancer. Eligible studies included 2,105,104 individuals and 4227 liver cancer cases. The main characteristics of the studies included in the meta-analysis are summarized in Table  1 . Two studies were conducted in USA [25, 34] , six in Europe [27, 28, [31] [32] [33] 36] , and five in Asia [29, 30, 35, 37, 38] . The follow-up in prospective cohort studies ranged from about 9 to 19 years, and the age range at study baseline was 20-79 years.
The summary RR of BTC for the highest versus lowest category of coffee consumption was 0.83, 95% CI: 0.64, 1.08, with no evidence of heterogeneity I 2 = 0%, p = 0.58 (Figure 2) . No publication bias was found after visual inspection of funnel plot ( Figure S1 ). The pooled estimations were RR = 0.84, 95% CI: 0.61, 1.15; I 2 = 22%, p = 0.27 for prospective cohort studies, and RR = 0.74, 95% CI: 0.34, 1.63; I 2 = 0%, p = 0.82 for case-control studies (Figure 2 ). The subgroup analysis was not performed due to the limited number of studies eligible for the meta-analysis. The summary RR of liver cancer for the highest versus lowest category of coffee consumption was RR = 0.52, 95% CI: 0.42, 0.63 with moderate heterogeneity I 2 = 44%, p = 0.02, (Figure 3 ). However, no publication bias was found after visual inspection of funnel plot ( Figure S2 ). The summary RR in separate analysis for prospective cohort studies was RR = 0.53, 95% CI: 0.41, 0.69; I 2 = 46%, p = 0.03, and RR = 0.48, 95% CI: 0.33, 0.70; I 2 = 47%, p = 0.08 for case-control studies (Figure 3) .
When considering sex and smoking status, no significant differences in comparison to main analysis of prospective cohorts were found (Table 2 ). In contrast, a significant decrease in risk of liver cancer for caffeinated coffee (RR = 0.65, 95% CI: 0.49, 0.86; I 2 = 0%, p = 0.59), but not for decaffeinated (RR = 0.85, 95% CI: 0.63, 1.14; I 2 = 0%, p = 0.96) was found ( Table 2 ). In the stratified analysis, a lower risk of liver cancer was found among studies conducted in European and Asian countries compared to USA, even though all results were statistically significant (Table 2) . Finally, stratified analysis by chronic hepatitis status did not significantly alter the results (Table 2 ). When considering sex and smoking status, no significant differences in comparison to main analysis of prospective cohorts were found (Table 2 ). In contrast, a significant decrease in risk of liver cancer for caffeinated coffee (RR = 0.65, 95% CI: 0.49, 0.86; I 2 = 0%, p = 0.59), but not for decaffeinated (RR = 0.85, 95% CI: 0.63, 1.14; I 2 = 0%, p = 0.96) was found ( Table 2 ). In the stratified analysis, a lower risk of liver cancer was found among studies conducted in European and Asian countries compared to USA, even though all results were statistically significant (Table 2) . Finally, stratified analysis by chronic hepatitis status did not significantly alter the results (Table 2) . 
Dose-Response Meta-Analysis
Three studies [23] [24] [25] were eligible for dose-response meta-analysis of prospective cohort studies on coffee consumption and BTC risk. In both non-linear and linear dose-response meta-analysis no significant association between coffee consumption and BTC risk was apparent ( Figure 4 , 
Three studies [23] [24] [25] were eligible for dose-response meta-analysis of prospective cohort studies on coffee consumption and BTC risk. In both non-linear and linear dose-response meta-analysis no significant association between coffee consumption and BTC risk was apparent ( Figure 4, Table 3 ). For the dose-response analysis on the association between coffee consumption and liver cancer risk, seven studies were eligible [25, [28] [29] [30] 32, 34, 38] . We found an evidence of linear association between coffee consumption and liver cancer risk (Pfor nonlinearity = 0.954) ( Figure 5 , Table 4 For the dose-response analysis on the association between coffee consumption and liver cancer risk, seven studies were eligible [25, [28] [29] [30] 32, 34, 38] . We found an evidence of linear association between coffee consumption and liver cancer risk (P for nonlinearity = 0.954) ( Figure 5 , Table 4 ). Compared with no coffee consumption, the pooled relative risks for liver cancer were: 0.82, 95% CI: 0.70, 0.98 for one cup/day; 0.68, 95% CI: 0.53, 0.88 for two cups/day; 0.57, 95% CI: 0.46, 0.70 for three cups/day; 0.47, 95% CI: 0.39, 0.56 for four cups/day; 0.39, 95% CI: 0.31, 0.50 for five cups/day; 0.33, 95% CI: 0.23, 0.46 for six cups/day; and 0.27, 95% CI: 0.17, 0.43 for seven cups/day. The associations were similar for men and women, although, in the analysis for women, a higher heterogeneity (P heterogeneity = 0.692) was observed. Table 4 . Dose-response meta-analysis of prospective cohort studies on coffee consumption and liver. 
Discussion
In the present meta-analysis, the inverse association between coffee consumption and risk of liver cancer was consistent when taking into account key potential confounding factors. In contrast, no significant association between coffee consumption and risk of BTC was evident. Notably, a non-significant decreased risk was found especially for lower intake of coffee (i.e., two cups/day); however, higher intake was associated with no further benefit or rather an increased risk in two out of the three cohorts examined. Furthermore, the limited number of the studies eligible for meta-analysis is not sufficient to draw conclusions on the association between coffee consumption and BTC risk. From a mechanistic point of view, intake of both caffeinated and decaffeinated coffee stimulates gallbladder contraction caused by increased concentration in plasma cholecystokinin induced by coffee and decreases gallbladder volume by approximately 30% [9] . Furthermore, coffee can exert a protective effect on gallbladder by decreasing the crystallization of cholesterol in bile [10] . However, induction of gallbladder contraction in patients with gallstones may induce the passage of gallstones to bile duct [7] . Overall, whilst a rationale for potential benefit exists, findings to date do not support such hypotheses. A possible reason for heterogeneity between results could depend on the different population involved that may have different health risk behaviours. For instance, higher intake of coffee was relatively poorly associated with alcohol consumption in the Northern European cohorts [39] , which showed a decreased risk of BTC. In contrast, coffee was associated with higher alcohol intake in Asian [40] and US cohorts [41] [42] [43] [44] [45] , which reported no benefits of coffee consumption on BTC risk. However, current data are not sufficient to reach final conclusions and further investigations are needed to clarify the relation between coffee consumption and BTC taking into account potential confounders.
Findings on coffee consumption and liver cancer risk were more consistent: all sensitivity and subgroup analyses performed showed significant decreasing risk of cancer with a linear dose-response relation. Molecular targets involved in the chemopreventive effects of coffee include the nuclear factor E2-related factor 2 (Nrf2), responsible for transcription of enzymes involved in detoxification processes and in cellular antioxidant defences [46] : a diet rich in coffee has been demonstrated to increase gene expression of NAD(P)H: quinone oxidoreductase 1, glutathione S-transferase class Alpha 1, UDP-glucuronosyl transferase 1A6, and the glutamate cysteine ligase catalytic subunit, all involved in the antioxidant response of the organism [47] . With special regard to hepatocellular carcinoma, coffee decreased the incidence of liver tumours in rats [48] , reduced the numbers of hyperplastic liver cell foci in chemical models of colon and liver cancer [49] , and reduced solid tumour growth, proliferation, and hepatoma metastases [50, 51] .
A number of experimental studies provided the biological rationale for the components responsible for beneficial effects of coffee on liver cells. In this meta-analysis, a significant decrease in risk of liver cancer for caffeinated coffee, but not for decaffeinated, was found. Caffeine has been reported to reduce fibrosis in in vitro and animal studies, inhibiting TGF-beta-induced CTGF (Connective Tissue Growth Factor) expression in hepatocytes by stimulation of degradation of the TGF-beta effector SMAD 2, inhibition of SMAD3 phosphorylation and up-regulation of the PPARgamma-receptor [52, 53] , as well as increased activity of superoxide dismutase and catalase in the liver and increased expression of Nrf2 [54] .
It has been shown that the caffeine metabolite paraxanthine may be responsible for the down-regulation of the expression of the fibrogenic protein CTGF in hepatic stellate cells and reduction of liver fibrosis and lipid peroxidation [55] . More recent investigations have shown that caffeine is not essential for the anti-fibrotic effects of coffee. It has been demonstrated in animal studies that both caffeinated and decaffeinated coffee reduce liver fibrosis and TGF-beta expression [56, 57] and that use of decaffeinated coffee is able itself to reduce liver steatosis, inflammation and fibrosis in animal models [58] . The phenolic compounds chlorogenic acids and caffeic acid are among the main candidates for the antioxidant effects of coffee on liver. Chlorogenic acids administration, or treatment in animal studies, reduces liver fibrosis through decreased expression of collagen I and collagen III, as well as reducing the expression of inflammatory cytokines, TLR4, myeloid differentiation factor 88, inducible nitric oxide synthase and cyclooxygenase-2 and nuclear factor-κB activation [59] [60] [61] . Caffeic acid reduces liver fibrosis due to its ability to suppress the activation of hepatic stellate cells by inhibiting oxidative stress through decrease of Keap1 expression, inhibition of Keap1 and Nrf2 binding, and thus activating Nrf2 and leading to increased expression of antioxidative signals [62] [63] [64] . Finally, coffee consumption may exert indirect protective effects on the liver due to the potential improvements of metabolism [3] . Coffee consumption has been inversely associated in several studies to metabolic syndrome [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] , which has been related to liver fat accumulation and liver impairment due to common pathogenic determinants, such as insulin resistance and oxidative stress; impaired metabolism may induce progressive liver damage, liver inflammation and fibrosis, which ultimately may lead to carcinogenic transformation [75] .
The results of the present study should be considered in the light of a number of limitations. First, some analyses reported moderate heterogeneity. As previously mentioned, several factors may explain differences across studies, including type of coffee bean (Arabica or Robusta), roasting, and beverage preparation. Secondly, genetic variants associated with caffeine metabolism are not considered in prospective cohort studies but were included in the meta-analysis and may contribute to the observed heterogeneity. Coffee consumption was assessed before outcome, thus recall bias is unlikely. However, misclassification of the actual amounts consumed may have affected the dose-response relation. Reverse causation may have affected the results if individuals changed coffee intake due to a diagnosed medical condition or disease; however, any such effects would be muted in studies with a long duration.
Conclusions
In conclusion, coffee may represent a valid functional food for liver protection. Current evidence is sufficient to guide future clinical randomized trials to test the hepatoprotective effects of coffee, which in turn may lead to more definitive recommendations. However, further observational studies with better in depth analyses of potential confounding factors are needed to test the association between coffee consumption and BTC.
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